What Reduces Homocysteine
Folic acid at 400-800 mcg daily reduces plasma homocysteine by approximately 25-30%, with vitamin B12 (0.4-1 mg daily) providing an additional 7% reduction. 1, 2, 3
Evidence-Based Interventions
B-Vitamin Supplementation (Primary Strategy)
The most effective approach to lowering homocysteine involves B-vitamin supplementation with specific dosing:
- Folic acid: 0.8 mg (800 mcg) daily achieves maximal homocysteine reduction of 23-25%. Lower doses of 0.2 mg and 0.4 mg provide approximately 60% and 90% of this maximal effect, respectively 3
- Vitamin B12 (cobalamin): 0.4-1 mg daily adds an additional 7% reduction beyond folic acid alone 1, 3
- Vitamin B6 (pyridoxine): Does NOT reduce fasting homocysteine levels, though it may lower post-methionine loading homocysteine 1, 2, 1
Dietary Approaches
Folic acid-fortified breakfast cereals are nearly as effective as supplements, producing a 24% reduction in homocysteine when providing approximately 300 mcg of folic acid daily 4. In contrast, increasing folate-rich foods alone produces only a 9% reduction despite similar folate intake increases, likely due to lower bioavailability 4.
A Mediterranean diet high in B-vitamins and folate is associated with lower plasma homocysteine 2.
Alternative Agents
N-acetylcysteine (NAC) at 1.8 g daily for 4 weeks reduces homocysteine by approximately 12%, regardless of lipid or smoking status, while simultaneously lowering blood pressure 5.
For patients with MTHFR 677TT genotype, oral 5-MTHF (5-methyltetrahydrofolate) should be considered since this active form bypasses the defective MTHFR enzyme 2.
When to Treat
Treat These Populations:
- Moderate hyperhomocysteinemia (15-30 μmol/L): Identify and reverse underlying cause (poor diet, vitamin deficiency, hypothyroidism, renal impairment, medications) 2
- Intermediate hyperhomocysteinemia (30-100 μmol/L): Usually due to moderate/severe cobalamin or folate deficiency or renal failure—treat with folate alone or combined with B12 and B6 2
- Severe hyperhomocysteinemia (>100 μmol/L): Requires cobalamin 0.02-1 mg daily due to increased prothrombotic state 2
- Homocystinuria with CBS deficiency: Pyridoxine 50-250 mg/day plus folic acid 0.4-5 mg/day and/or vitamin B12 0.02-1 mg/day; betaine as adjunct 2
- Dialysis patients: Routine vitamin supplementation to replace dialysis losses and prevent additive elevation 6
Do NOT Routinely Treat:
General population with normal homocysteine levels: Current data do not support pharmacological B-vitamin treatment for primary or secondary cardiovascular prevention in unselected populations 2, 7, 8, 9. Multiple large trials (HOPE-2, VISP, NORVIT, WAFACS) showed no reduction in cardiovascular events despite effective homocysteine lowering 7, 8, 9.
Critical Caveats
Folic acid supplementation may mask vitamin B12 deficiency, particularly in older individuals, potentially allowing neurological damage to progress 1. Always assess B12 status before initiating high-dose folic acid.
Food fortification populations (e.g., North America): Additional pharmacological folic acid provides no vascular benefit beyond the 400 mcg/day from fortified foods, as intracellular 5-MTHF reaches maximum despite higher plasma levels 2.
Vitamin B6 has no effect on fasting homocysteine despite being commonly included in B-complex formulations 1.
Practical Approach
For elevated homocysteine (>14-15 μmol/L):
- Identify underlying cause (nutritional deficiency, renal function, medications, genetic factors)
- Start folic acid 0.8 mg daily plus vitamin B12 0.4-1 mg daily
- Target homocysteine <10 μmol/L 1
- Monitor B12 status to avoid masking deficiency
- Consider 5-MTHF for MTHFR mutations
- Reassess after 6 weeks; homocysteine increases if supplementation stops 10
The effectiveness rating for therapeutic homocysteine lowering in peripheral arterial disease remains Class IIb (not well established) because lowering homocysteine has not been proven to improve clinical cardiovascular outcomes 1.